Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Conradi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacology and Therapeutics|December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|August 1, 1979
Presystemic and systemic glucuronidation of propranololT Walle, T C Fagan, E C Conradi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1990
Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in manT Walle, U K Walle, T D Cowart, et al.
British Journal of Clinical Pharmacology|January 1, 1994
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomersU K Walle, T C Fagan, M J Topmiller, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesisL S Olanoff, T Walle, T D Cowart, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolitesT Walle, T C Fagan, U K Walle, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1983
Time course of development of the antihypertensive effect of propranololT C Fagan, T Walle, R Corns-Hurwitz, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Antihypertensive effects of lofexidine in patients with essential hypertensionT C Fagan, S S Bloomfield, T D Cowart, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Pharmacology and Therapeutics|December 1, 1979
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|January 1, 1980
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranololT Walle, E C Conradi, U K Walle, et al.
Clinical Pharmacology and Therapeutics|August 1, 1979
Presystemic and systemic glucuronidation of propranololT Walle, T C Fagan, E C Conradi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1990
Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in manT Walle, U K Walle, T D Cowart, et al.
British Journal of Clinical Pharmacology|January 1, 1994
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomersU K Walle, T C Fagan, M J Topmiller, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesisL S Olanoff, T Walle, T D Cowart, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Food-induced increase in propranolol bioavailability--relationship to protein and effects on metabolitesT Walle, T C Fagan, U K Walle, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1983
Time course of development of the antihypertensive effect of propranololT C Fagan, T Walle, R Corns-Hurwitz, et al.
British Journal of Clinical Pharmacology|March 1, 1982
Antihypertensive effects of lofexidine in patients with essential hypertensionT C Fagan, S S Bloomfield, T D Cowart, et al.
Pageof 2